Two acellular pertussis vaccines, a mono-component toxoid of pertussis toxin and a two-
component vaccine containing both the toxoid and filamentous haemagglutinin, were used …

An acellular pertussis vaccine principally containing two purified pertussis antigens,
filamentous hemagglutinin and lymphocytosis-promoting factor, combined with diphtheria …

Of 342 cases with pertussis notified from 1986 through 1989 in Aichi Prefecture, Japan, 331
(96.8%) were unimmunized children. To confirm the clinical efficacy of the acellular pertussis …

OBJECTIVE: To estimate the contribution of whole-cell pertussis vaccine to severe local
reactions after the preschool (fifth) dose of adsorbed diphtheria toxoid-pertussis vaccine …

In a multicenter, double-blind, randomized, longitudinal study, 252 children recelved
licensed Lederie diphtheria-tetanus toxoids and pertussis vaccine adsorbed (DTP) at 2, 4 …

A randomized, double-blind trial comparing a diphtheria-tetanus-acellular pertussis vaccine
(DTaP)(pertussis toxoid and filamentous hemagglutinin) with a whole-cell vaccine (DTwP) …

Abstract Purified acellular pertussis vaccine (12.5 µg of lymphocytosis promoting factor [LPF]
and 12.5 µg of filamentous hemagglutinin [FHA]) was compared with conventional pertussis …

Compared to whole cell pertussis (wcP) vaccines, acellular pertussis vaccines (aP) have a
better safety profile with lower reactogenicity, although their short and long-term efficacy was …

Background. We conducted a 5-year follow-up study on the persistence of pertussis-specific
antibody and cell-mediated immunity after booster immunization of adolescents aged 11–13 …

Objective. To compare prospectively the reactogenicity and immunogenicity of two licensed
whole-cell pertussis vaccines. Methods. We conducted a prospective, randomized, double …